Greater transparency in drug pricing urged for Ireland

08/5/2013 | (Ireland)

Meetings about how to increase competition and reduce prescription drug prices in Ireland's pharmacy sector took place last month between the National Consumer Agency, the Competition Authority and the Troika – which is made up of the European Central Bank, the European Commission and the International Monetary Fund. The National Consumer Agency has decried what it says is a lack of clarity in drug pricing following a survey that found considerable variation in the prices of prescription medicines. The Irish Pharmacy Union pointed out that posting prices for more than 7,000 prescriptions would be "impractical," and that prices are set by the government's Health Service Executive and the major drug manufacturers.

View Full Article in: (Ireland)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI